+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Facial Fat Transfer Market Size, Share & Trends Analysis Report by Donor Site (Thigh, Flank, Abdomen), by End-use (Hospitals, Clinics & Surgery Center), by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 100 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 5595885
The global facial fat transfer market size is anticipated to reach USD 4.9 billion by 2030, advancing at a CAGR of 10.8% during the forecast period. The growth of the market is attributed to the various benefits of fat grafting, along with the growing geriatric population. Furthermore, technological advancements in aesthetic devices are also anticipated to fuel market growth.



According to United Nations data, individuals above the age of 65 years accounted for nearly 9% in 2019, while the number is estimated to reach nearly 11% by 2050. The facial skin of aging people is prone to deep wrinkles, dry skin, volume loss, and elasticity loss, thereby driving the market growth. Furthermore, the increasing usage of social media, beauty apps, and the extensive marketing techniques of skincare & aesthetic device companies have led to an increasing obsession with flawless skin and the desire to look perfect.

Research carried out by Boston Medical Center in 2019 reported that 55% of plastic surgeons report seeing patients willing to improve their appearance in selfies. The facial fat transfer market is characterized by the presence of a few established players and several start-ups or small enterprises. This can be attributed to the presence of ambiguous regulatory scenarios and a capital-intensive product development process. Furthermore, the clinicians & plastic surgeons performing these procedures are also limited in number and charge a high fee, thus significantly affecting the adoption of this technique.

The onset of COVID-19 disrupted the aesthetic market significantly in the first and second quarters of 2020, due to low patient footfall and the risk of virus transmission. The procedure volume for facial fat transfer treatments also witnessed a decline in 2020. However, the market is expected to witness a recovery as the demand for aesthetic treatments escalated in the post-pandemic period.

Facial Fat Transfer Market Report Highlights

  • The current demand for facelifts and other facial aesthetic cosmetic procedures is mainly due to individuals’ dissatisfaction with appearance and a strong desire for a youthful appearance.
  • Fat transfer procedures with the abdomen as a donor site dominated the market in 2021. This can be attributed to the high adipocyte viability of fat obtained from this region.
  • North America dominated the regional market in 2021. This can be attributed to the greater availability and adoption of advanced treatment options in this region.
  • The Asia Pacific region is anticipated to witness lucrative growth during the forecast period. This can be attributed to the rising disposable income and increasing awareness regarding various aesthetic procedures among regional consumers.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Facial Fat Transfer Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing aging population
3.3.1.2. Growing demand for cosmetic procedures
3.3.1.3. Benefits of autologous fat transfer over derma fillers
3.3.2. Market Restraint Analysis
3.3.2.1. Shortcomings of the procedure limiting mass adoption
3.3.2.2. Uncertain regulations
3.4. Facial Fat Transfer: Market Analysis Tools
3.4.1. Industry Analysis-Porter’s Five Forces Analysis
3.4.1.1. Supplier Power
3.4.1.2. Buyer Power
3.4.1.3. Substitution Threat
3.4.1.4. Threat from new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Environmental Landscape
3.4.2.3. Social Landscape
3.4.2.4. Technology Landscape
3.4.2.5. Legal Landscape
Chapter 4. Facial Fat Transfer Market: Segment Analysis, by Donor Site, 2018-2030 (USD Million)
4.1. Definitions & Scope
4.2. Donor Site market share analysis, 2022 & 2030
4.3. Global Facial Fat Transfer Market, by Donor Site, 2018 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Thigh
4.4.2. Abdomen
4.4.3. Flanks
Chapter 5. Facial Fat Transfer Market: Segment Analysis, by End-use, 2018-2030 (USD Million)
5.1. Definitions & Scope
5.2. End-use market share analysis, 2022 & 2030
5.3. Global Facial Fat Transfer Market, by End-use, 2018 to 2030
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Hospitals
5.4.2. Clinics & surgery centers
Chapter 6. Facial Fat Transfer Market: Regional Market Analysis, by Region, 2018-2030 (USD Million)
6.1. Definitions & Scope
6.2. Regional market share analysis, 2022 & 2030
6.3. Regional Market Dashboard
6.4. Regional Market: Key Players
6.5. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030
6.6. North America
6.6.1. Market estimates and forecast, by country, 2018-2030 (USD Million)
6.6.2. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.6.3. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.6.4. U.S.
6.6.4.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.6.4.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.6.5. Canada
6.6.5.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.6.5.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.7. Europe
6.7.1. Market estimates and forecast, by country, 2018-2030 (USD Million)
6.7.2. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.7.3. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.7.4. U.K.
6.7.4.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.7.4.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.7.5. Germany
6.7.5.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.7.5.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.7.6. France
6.7.6.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.7.6.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.7.7. Italy
6.7.7.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.7.7.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.7.8. Spain
6.7.8.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.7.8.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.8. Asia Pacific
6.8.1. Market estimates and forecast, by country, 2018-2030 (USD Million)
6.8.2. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.8.3. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.8.4. Japan
6.8.4.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.8.4.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.8.5. China
6.8.5.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.8.5.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.8.6. India
6.8.6.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.8.6.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.8.7. Australia
6.8.7.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.8.7.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.8.8. South Korea
6.8.8.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.8.8.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.9. Latin America
6.9.1. Market estimates and forecast, by country, 2018-2030 (USD Million)
6.9.2. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.9.3. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.9.4. Brazil
6.9.4.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.9.4.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.9.5. Mexico
6.9.5.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.9.5.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.9.6. Argentina
6.9.6.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.9.6.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.9.7. Colombia
6.9.7.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.9.7.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.10. Middle East and Africa
6.10.1. Market estimates and forecast, by country, 2018-2030 (USD Million)
6.10.2. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.10.3. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.10.4. South Africa
6.10.4.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.10.4.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.10.5. Saudi Arabia
6.10.5.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.10.5.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
6.10.6. UAE
6.10.6.1. Market estimates and forecast, by donor site, 2018-2030 (USD Million)
6.10.6.2. Market estimates and forecast, by End-use, 2018-2030 (USD Million)
Chapter 7. Facial Fat Transfer Market-Competitive Analysis
7.1. Key companies profiled
7.1.1. Ranfac Corp
7.1.1.1. Company Overview
7.1.1.2. Product Benchmarking
7.1.1.3. Strategic Initiatives
7.1.2. Alma Lasers
7.1.2.1. Company Overview
7.1.2.2. Product Benchmarking
7.1.2.3. Strategic Initiatives
7.1.3. Allergan Plc
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Genesis Biosystems
7.1.4.1. Company Overview
7.1.4.2. Product Benchmarking
7.1.4.3. Strategic Initiatives
7.1.5. Stanford Health Care
7.1.5.1. Company Overview
7.1.5.2. Product Benchmarking
7.1.5.3. Strategic Initiatives
7.1.6. Emory Healthcare
7.1.6.1. Company Overview
7.1.6.2. Product Benchmarking
7.1.6.3. Strategic Initiatives

Companies Mentioned

  • Ranfac Corp
  • Alma Lasers
  • Allergan plc
  • Genesis Biosystems
  • Stanford Health Care
  • Emory Healthcare

Methodology

Loading
LOADING...

Table Information